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Abstract
In 1995 the genome sequence of the Haemophilus inﬂuenzae KW20 (Rd) strain
was published, the ﬁrst available for a free-living organism. The genome has been
invaluable in global strategies to identify certain virulence-related genes, e.g. those
involved in LPS synthesis, and also essential genes, but there is a paucity of whole-
genome transcriptome studies. We have now constructed a whole-genome array
consisting of genes from Rd, additional genes identiﬁed in other strains of H.
inﬂuenzae and controls (from eukaryotic sources and other bacteria). We intend to
use this array in studies aimed at understanding the bacterium’s basic metabolism
and its response to changing environments; deciphering global regulatory networks
(by comparison of wild-type and mutant strains); and identifying genes expressed
in vivo. The use of H. inﬂuenzae DNA arrays combined with proteomic approaches
will enhance our understanding of the metabolism and virulence of the organism.
Additionally, the genome sequence of a non-typable H. inﬂuenzae strain is in progress.
The sequence from this isolate will be invaluable not only in identifying potential
novel antibiotic targets and putative vaccine candidates but also in the design of a
microarray for genome-typing purposes. Copyright  2002 John Wiley & Sons, Ltd.
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Haemophilus inﬂuenzae is a non-motile Gram-
negative bacterium with fastidious growth require-
ments. Capsulate strains, and in particular type b
strains with a polyribosyl ribitol phosphate cap-
sule, can cause life-threatening infections, includ-
ing meningitis, sepsis and epiglottitis. However,
the availability for the past 15 years of a highly
effective vaccine has led to a dramatic decrease
in disease caused by type b strains in the devel-
oped world, although infections are still a sig-
niﬁcant problem in the developing world. Cur-
rently, considerable research effort is being devoted
to non-typable H. inﬂuenzae strains (strains that
do not possess a capsule), since they are a
major cause of respiratory tract infection, includ-
ing otitis media, sinusitis and pneumonia, as
well as exacerbation of disorders such as chronic
bronchitis or cystic ﬁbrosis. Research is being
driven by the need to understand pathogenesis
in order to produce a vaccine effective against
diverse strains.
A signiﬁcant claim to fame is that a strain of
H. inﬂuenzae (KW 20, Rd) was the ﬁrst free-living
organism to have its whole genome sequenced [4].
The 1,830,138 bp genome (Genbank Accession
No. L42023) is predicted to encode 1714 pro-
teins. Among many features of interest are the
comparative paucity of two-component systems
(four sensors/ﬁve regulators compared to 40 sen-
sor–regulator pairs in Escherichia coli); the lack
of three enzymes of the tricarboxylic acid (TCA)
cycle (citrate synthase, isocitrate dehydrogenase
and aconitase); and, as has been found subse-
quently in many prokaryotic genomes, approxi-
mately one-third of genes — unique or conserved
hypotheticals — being of unknown function. A
comprehensive comparison of the H. inﬂuenzae
genome with that of E. coli was made by Tatusov
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et al. [9]. These authors highlighted striking dif-
ferences in both the repertoire of genes and their
arrangement in the two bacterial chromosomes.
In particular the 2.5-fold reduction in the num-
ber of genes in H. inﬂuenzae compared with E.
coli is partly a result of the absence of many
functional systems, notably pathways of carbo-
hydrate utilization and respiratory chains. Their
conclusion was that the repertoire of metabolic
enzymes in H. inﬂuenzae was tuned towards reduc-
ing conditions — that the bacterium has a largely
anaerobic metabolism. It should be noted that Rd
lacks approximately 300 kb of chromosomal DNA
found in clinical isolates. Some of these ’miss-
ing’ genes are known, e.g. ﬁmbrial and capsula-
tion loci [4], and remarkably, capsulation genes
alone can convert non-virulent Rd to being as
virulent as wild-type strains in the infant rat
model [10].
To date, comparatively few studies have made
extensive use of the genomic information obtained
from Rd. Notable exceptions are the studies of
Moxon and colleagues [6,7] and Akerley et al.[ 1 ] .
In the former studies the Rd genome was interro-
gated and, by comparison with sequences of known
LPS biosynthetic genes from other organisms, 25
candidate LPS genes were identiﬁed and cloned.
Virulence studies in the infant rat of wild-type
and knock-out mutant strains allowed the minimal
LPS structure required for intravascular dissemina-
tion to be determined [6]. In the second study [7],
the Rd genome sequence was searched to iden-
tify nine novel loci with multiple (range 6–36,
mean 22) tandem tetranucleotide repeats. All were
found to be located within putative open reading
frames (ORFs), which included a homologue of
the neisserial glycosyltransferase lgtC. Mutation of
this HaemophiluslgtC-homologue resulted in atten-
uated virulence in the infant rat model of invasive
infection. The authors concluded that their studies
indicated ’the rapidity, economy, and complete-
ness with which whole genome sequences can be
used to investigate the biology of pathogenic bac-
teria’. Akerley et al. [1] used a high-density trans-
poson mutagenesis strategy to estimate that 38%
of Rd genes are required for growth or viabil-
ity in rich media. A number of putative essen-
tial genes (259) lacked deﬁned functional roles.
It was concluded that essentiality was not pre-
dicted by conservation across species, and that
genes needed in one organism are not necessarily
needed in another.
Given that the whole genome of H. inﬂuen-
zae was the ﬁrst available, it is somewhat sur-
prising that only two papers have been published
to date reporting the use of the data to con-
struct DNA arrays for transcriptome analysis. de
Saizieu et al. [3] designed a high-density oligonu-
cleotide probe array (Affymetrix chip) containing
probes representing 106 H. inﬂuenzae genes and
100 Streptococcus pneumoniae genes, but only
reported the results of probing with chemically
biotinylated RNA from S. pneumoniae grown up
in rich media. Not surprisingly, there was little
cross-reactivity of the S. pneumoniae RNA with
oligonucleotides representing H. inﬂuenzae genes.
Gmuender et al. [5] used an Rd whole-genome
Affymetrix chip to investigate the transcriptome
of the bacterium exposed to DNA gyrase inhibitor
antibiotics of two functional classes during growth
in minimal media. Novobiocin inhibits the ATPase
activity of the enzyme, indirectly changing the
degree of DNA supercoiling, whilst ciproﬂoxacin
obstructs supercoiling by inhibiting the DNA-
cleavage-resealing reaction. With novobiocin the
expression rate of many genes changed, reﬂect-
ing that their transcription initiation is sensitive
to DNA supercoiling. In contrast, ciproﬂoxacin
mainly stimulated the expression of DNA repair
systems in response to DNA damage. Time course
and antibiotic concentrations were varied, and
when all experiments were taken into account, 85%
of transcribed genes were detected. A number of
the genes whose expression levels changed were
those of unknown function or conserved hypo-
thetical genes. This study was extremely compre-
hensive in that samples were also analysed by
two-dimensional electrophoresis (2DE). The inten-
sity of signals on the Affymetrix chips was com-
pared to that of the protein spots detected on
2DE gels and a correlation coefﬁcient of 0.5
found. Possible reasons suggested for this low
correlation were bias on cDNA synthesis, chip
variation and the technical constraints of 2DE
resulting in non-detection of proteins. However,
this study amply demonstrates the power of H.
inﬂuenzae gene arrays to give insight into the
bacterial transcriptional consequences of antibi-
otic treatment.
Our laboratory has a long-standing interest in
understanding both the basic biology and the
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molecular basis of pathogenicity of H. inﬂuen-
zae. Advantages of working with H. inﬂuenzae as
a model organism include the ease with which
mutants can in general be made, the availability
of an animal model that closely mimics human
disease, and the availability of various in vitro sur-
rogate models (tissue culture) of different phases of
infection. To complement such techniques we have,
in collaboration with Philip Butcher and Jason
Hinds at the Bacterial Microarray Group at St.
George’s Hospital Medical School in London, con-
structed a whole-genome array of H. inﬂuenzae for
transcriptome analysis. This follows on from our
initial studies with a partial genome array of H.
inﬂuenzae [2]. Primers were designed to amplify
regions of all the ORFs — excluding the structural
RNAs — chosen so that they would show mini-
mum cross-hybridization within the H. inﬂuenzae
genome. In addition to ORFs from H. inﬂuenzae
Rd, we have included ORFs from other strains
of H. inﬂuenzae (i.e. those not present in Rd)
as well as ORFs from eukaryotic cells (as well
as other bacterial species) to act as controls. We
plan to use these arrays to identify genes that are
expressed in vivo. It is ﬁrmly established that bac-
teria grown in vitro and in vivo express different
sets of genes, reﬂecting adaptation to quite dif-
ferent environments, and in particular the need to
survive the comparatively hostile environment pro-
vided by the host. The suggestion from the Tatusov
analysis of the genome is that H. inﬂuenzae is
adapted to growth in a more anaerobic environ-
ment. We shall determine the in vivo transcriptome
of H. inﬂuenzae by isolating bacteria directly from
experimentally infected animals and from in vitro
surrogate models (tissue culture) and compare it
to that relevant to bacteria grown in vitro. These
experiments are not without practical and inter-
pretative difﬁculties. First, there is the problem of
isolating sufﬁcient bacteria to obtain enough RNA
for microarray analysis. This is dependent on the
model system used. Second, the bacteria should
ideally be free of host cell RNA; and third, meth-
ods requiring minimal sample manipulation will
be essential to preserve material for analysis. The
use of RNA-stabilizing agents, such as RNALater
(Ambion), may be useful in this regard. In exper-
iments of this kind, the conditions in which the
comparator organisms are grown are of course cru-
cial, and the choice of broth culture for ’baseline’ is
often rightly challenged. Considerable caution will
be needed in the interpretation of results obtained
from in vivo vs. broth-grown organisms, but it
is reasonable to hope that data should be gener-
ated to identify genes or pathways to be given
priority targeting in future studies. It should also
be possible to formulate in vitro growth conditions
that mimic the in vivo situation more closely, aid-
ing for example identiﬁcation of potential novel
targets for antibiotic action. The availability of a
whole-genome array for H. inﬂuenzae should also
be invaluable in other areas of research: e.g. it
will be possible to compare the transcriptome of
bacteria grown under different in vitro growth con-
ditions or in response to imposed environmental
stresses. Alternatively, the response of wild-type
and isogenic non-polar mutant strains under deﬁned
growth conditions can be compared. It should also
be remembered that the transcriptome obtained is
a snapshot. Comparatively few transcriptome stud-
ies have been formulated as time course analyses
because of experimental or cost constraints. Such
analysis may be crucial in establishing the signif-
icance of data. However, a systematic approach
with good experimental design in combination with
analysis of the metabolic pathways [8] should lead
to the identiﬁcation of the regulatory networks of
H. inﬂuenzae. Additionally, transcriptome analy-
sis should be combined with proteome analysis,
as exempliﬁed by Gmuender et al. [5], who used
2DE analysis.
Whilst at present there is only one publication
describing the use of whole-genome arrays with
H. inﬂuenzae, in the coming years we can predict
that there will be increased interest once again in
this organism, both for the reasons stated already,
and because a non-typable strain is currently
being sequenced (http://www.microbial-pathoge-
nesis.org/H.inﬂuenzae.86028/). This should be
available within 2 years, and it is expected that
this will be used in the identiﬁcation of poten-
tial vaccine as well as novel therapeutic targets.
A DNA array of a non-typable strain will also
be useful for genome-typing. In this technique,
genomic DNA is hybridized to DNA arrays and
the hybridization patterns used to identify genes
present or absent in strains. This is useful in
epidemiological investigations and for identifying
potential pathogenicity islands. Non-typable strains
are known to have a larger genome than Rd and be
a relatively genetically diverse population, hence
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genome-typing may be a valuable tool for use with
these bacteria.
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